Endomyocardial fibrosis
MONDO:0006746A disease characterized by fibrotic thickening of the endocardium, particularly the right and/or left inflow tracts. The disease often involves the atrioventricular valves, leading to valvular regurgitaion. It most commonly occurs in children living within 15 degrees of the equator.
Also known as: African endomyocardial fibrosis
24 clinical trials for this condition and its sub-types, 16 tagged with Endomyocardial fibrosis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Hormone therapy may shield menopausal hearts and brains — a trial puts it to the test
Disease control Not yet recruitingThis trial explores whether starting transdermal estradiol (a skin gel or patch) soon after menopause can protect the heart and brain in women who have hot flashes and at least one cardiovascular risk factor. One hundred women will be randomly assigned to receive the hormone ther…
Phase 4 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Smartphone coaching aims to reverse heart damage from high blood pressure
Disease control Not yet recruitingThis study tests whether a 12-month digital program with health coaching and a wearable device can reduce scarring in the heart muscle caused by high blood pressure. Researchers will enroll 200 adults aged 40-70 with early signs of heart thickening. The goal is to see if lifestyl…
Sponsor: National University of Singapore • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC